BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takeuchi N, Nonen S, Kato M, Wakeno M, Takekita Y, Kinoshita T, Kugawa F. Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation. Neuropsychobiology 2017;75:81-8. [PMID: 29131015 DOI: 10.1159/000480512] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Micale V, Di Bartolomeo M, Di Martino S, Stark T, Dell'osso B, Drago F, D'addario C. Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. Pharmacology & Therapeutics 2022. [DOI: 10.1016/j.pharmthera.2022.108279] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Manu DM, Mwinyi J, Schiöth HB. Challenges in Analyzing Functional Epigenetic Data in Perspective of Adolescent Psychiatric Health. Int J Mol Sci 2022;23:5856. [PMID: 35628666 DOI: 10.3390/ijms23105856] [Reference Citation Analysis]
3 Sales AJ, Guimarães FS, Joca SRL. DNA methylation in stress and depression: from biomarker to therapeutics. Acta Neuropsychiatr 2021;33:217-41. [PMID: 34348819 DOI: 10.1017/neu.2021.18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhou J, Li M, Wang X, He Y, Xia Y, Sweeney JA, Kopp RF, Liu C, Chen C. Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. Front Neurosci 2021;15:674273. [PMID: 34054421 DOI: 10.3389/fnins.2021.674273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
5 Martinez-Pinteño A, Rodriguez N, Blázquez A, Plana MT, Varela E, Gassó P, Lafuente A, Lazaro L, Mas S. DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results. Pharmgenomics Pers Med 2021;14:459-67. [PMID: 33907441 DOI: 10.2147/PGPM.S289480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Czarny P, Białek K, Ziółkowska S, Strycharz J, Barszczewska G, Sliwinski T. The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder. J Pers Med 2021;11:167. [PMID: 33804455 DOI: 10.3390/jpm11030167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Sun L, Verkaik-Schakel RN, Biber K, Plösch T, Serchov T. Antidepressant treatment is associated with epigenetic alterations of Homer1 promoter in a mouse model of chronic depression. J Affect Disord 2021;279:501-9. [PMID: 33128940 DOI: 10.1016/j.jad.2020.10.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Sales AJ, Maciel IS, Suavinha ACDR, Joca SRL. Modulation of DNA Methylation and Gene Expression in Rodent Cortical Neuroplasticity Pathways Exerts Rapid Antidepressant-Like Effects. Mol Neurobiol 2021;58:777-94. [PMID: 33025509 DOI: 10.1007/s12035-020-02145-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Katou M. Clinical Pharmacological Research for Precision Medicine in Psychiatry with Genomics, Epigenomics and Informatics. Jpn J Clin Pharmacol Ther 2020;51:213-219. [DOI: 10.3999/jscpt.51.213] [Reference Citation Analysis]
10 Webb LM, Phillips KE, Ho MC, Veldic M, Blacker CJ. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review. Int J Mol Sci 2020;21:E826. [PMID: 32012861 DOI: 10.3390/ijms21030826] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
11 Wang AL, Gruzieva O, Qiu W, Kebede Merid S, Celedón JC, Raby BA, Söderhäll C, DeMeo DL, Weiss ST, Melén E, Tantisira KG. DNA methylation is associated with inhaled corticosteroid response in persistent childhood asthmatics. Clin Exp Allergy 2019;49:1225-34. [PMID: 31187518 DOI: 10.1111/cea.13447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kugawa F. Meet Our Editorial Board Member. CCP 2019;14:1-1. [DOI: 10.2174/157488471401190301120023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Hack LM, Fries GR, Eyre HA, Bousman CA, Singh AB, Quevedo J, John VP, Baune BT, Dunlop BW. Moving pharmacoepigenetics tools for depression toward clinical use. J Affect Disord 2019;249:336-46. [PMID: 30802699 DOI: 10.1016/j.jad.2019.02.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
14 Goud Alladi C, Etain B, Bellivier F, Marie-Claire C. DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. Int J Mol Sci 2018;19:E3026. [PMID: 30287754 DOI: 10.3390/ijms19103026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]